[1]
2019. The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren’s syndrome. Clinics. 74, (Jun. 2019), e631. DOI:https://doi.org/10.6061/clinics/2019/e631.